Has Humana turned the corner? Stock jumps as outlook raised, Medicare business improves - MarketWatch
1. Humana's strong Q2 results surpassed Wall Street expectations. 2. 2025 EPS guidance raised to approximately $17.00, exceeding analyst estimates. 3. Medicare Advantage membership loss projected lower than previous estimates. 4. Total revenue for Q2 grew 9.6%, beating forecasts significantly. 5. HUM stock surged 8.3%, indicating strong market reaction post-earnings.